ELETRIPTAN HBR 20 MG TABLET
For 30 tablets
Pharmacies pay
$51.88 filed
30 × $1.72929 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$64.66 estimated
$51.88 + $7.78 (15%) + $5.00 fee per fill = $64.66
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ELETRIPTAN HBR 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as eletriptan hydrobromide.
FDA gives its dosage form as tablet, film coated and its route as oral.
FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Serotonin-1b and Serotonin-1d Receptor Agonist.
The NADAC file of 2026-10-14 prices it under 9 NDCs (National Drug Codes); the FDA directory lists 5 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $51.88 for 30 tablets (30 × $1.72929 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 5 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Aurobindo Pharma Limited | 1 | $1.72929 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $1.72929 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $1.72929 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $1.72929 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 1 | $1.72929 per EA filed |
| Not listed as a package in the FDA directory | 4 | $1.72929 per EA filed |
All 9 NDCs, with labeler and price
- 00093-8310-18 · Teva Pharmaceuticals USA, Inc. · $1.72929 per EA · eff. 2026-09-23 filed
- 00093-8310-19 · not listed as a package in the FDA directory · $1.72929 per EA · eff. 2026-09-23 filed
- 00378-4287-32 · not listed as a package in the FDA directory · $1.72929 per EA · eff. 2026-09-23 filed
- 00378-4287-85 · Mylan Pharmaceuticals Inc. · $1.72929 per EA · eff. 2026-09-23 filed
- 27241-0039-68 · not listed as a package in the FDA directory · $1.72929 per EA · eff. 2026-09-23 filed
- 31722-0443-31 · Camber Pharmaceuticals, Inc. · $1.72929 per EA · eff. 2026-09-23 filed
- 59651-0104-06 · not listed as a package in the FDA directory · $1.72929 per EA · eff. 2026-09-23 filed
- 59651-0104-69 · Aurobindo Pharma Limited · $1.72929 per EA · eff. 2026-09-23 filed
- 68382-0922-86 · Zydus Pharmaceuticals USA Inc. · $1.72929 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name eletriptan hydrobromide with ELETRIPTAN HBR 20 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ELETRIPTAN HBR 20 MG TABLET this page | $1.72929 per EA filed | We don’t know yet |
| ELETRIPTAN HBR 40 MG TABLET | $1.74515 per EA filed | We don’t know yet |
| RELPAX 20 MG TABLET | $77.37047 per EA filed | $77.50329 per EA filed |
| RELPAX 40 MG TABLET | $77.04869 per EA filed | $77.50329 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 9 NDCs’ NADAC prices is $1.72929 per EA filed.
Of the 28 other products in FDA’s Serotonin-1b and Serotonin-1d Receptor Agonist class priced per EA, 18 have a higher middle NADAC price and 10 a lower one. The one in the middle is FROVATRIPTAN SUCC 2.5 MG TAB, at $2.71707 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- RIZATRIPTAN 10 MG TABLET
- NARATRIPTAN HCL 2.5 MG TABLET
- ZOLMITRIPTAN 2.5 MG TABLET
- FROVATRIPTAN SUCC 2.5 MG TAB
- ALMOTRIPTAN MALATE 12.5 MG TAB